Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
about
Mitomycin C for prevention of postoperative haze following excimer laser surface ablation in moderate to high myopiaEvaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical studyCorneal molecular and cellular biology update for the refractive surgeon.Long-term analysis of LASIK for the correction of refractive errors after penetrating keratoplasty.Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: preoperative and postoperative ultrasound biomicroscopic examination and short-term clinical outcomes with and without an antihyperopia treatment.Visual outcomes of topography-guided excimer laser surgery for treatment of patients with irregular astigmatism.Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbitsDelayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C.Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery.Outcomes of photorefractive keratectomy with intraoperative mitomycin-CEffects of differenta mitomycin C concentrations on laser-assisted subepithelial keratectomyTwo-step versus Single Application of Mitomycin-C in Photorefractive Keratectomy for High MyopiaQuiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healingPhotorefractive Keratectomy for Residual Myopia after Myopic Laser In Situ Keratomileusis.Fibrogenesis in Crohn's disease.Uses and complications of mitomycin C in ophthalmology.Comparison of standard and low dose intraoperative mitomycin C in prevention of corneal hazeafter photorefractive keratectomy.Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspensionCorneal Regeneration After Photorefractive Keratectomy: A Review.Establishment of in vitro model of corneal scar pathophysiology.Quercetin and the ocular surface: What we know and where we are going.Long term followup of photorefractive keratectomy with adjuvant use of mitomycin C.Visual performance after excimer laser photorefractive keratectomy for high myopia.Central corneal haze after wedge resection following penetrating keratoplasty and photorefractive keratectomy.Laser and topical mitomycin C for management of nasal synechia after FESS: a preliminary report.Short-term response of mitomycin C on the human rectus muscle following strabismus surgery: histological, ultrastructural, and biomechanical evaluation.Mitomycin C 0.02 and 0.002% efficacy in preventing haze after photorefractive keratectomy.Refractory interface haze developing after epithelial ingrowth following laser in situ keratomileusis and small aperture corneal inlay implantation.
P2860
Q24242548-4BECF28A-3B55-43BA-8E9C-6986F9DEE8D2Q24795964-F91EED36-895D-43A4-A2A7-0F3679AB3251Q30865099-C2B64EE0-D247-4781-9ABF-1196A0E3159CQ30883258-33E52A35-306D-4598-A98D-D394F7692DA4Q31048585-F1C1C4D6-718C-49A3-B8CA-740012C996FDQ31111564-98FE8E2C-C70B-46A0-AEC0-8040ACE8A741Q33248136-843025AA-E3B2-4CC5-A301-5A7D4D8E6870Q33573980-C7F3077C-9E8C-4A1C-B0AD-C15EFB6E50BFQ33862867-62ECF3F1-98F3-4F2A-9166-9C2729A6C325Q33873505-D928CA04-B9B0-4E67-86D0-94F7B93E909EQ33997504-5740547E-9F9C-4ACA-8B01-AE2F3B277056Q34130123-6C34BD28-769E-45DC-914D-DB95F7DBB6EDQ34439656-5E46B978-4580-4503-AD0A-D1DA0AE7356CQ34496465-8231A152-CE34-411C-975D-1A3C35952A9DQ35187495-6431AAD0-B55A-49C0-B583-9F6AD7D22914Q36052259-D3D0A113-47AB-4656-BE59-C53FCC139583Q36099710-141586FB-79EC-42E9-91A7-FB57CEDFC110Q36272419-17B3758B-9280-461E-B9D3-831E3058A05CQ36677634-C11F4A3A-F0FD-4019-9543-E689D6E47A88Q36689056-B9DEB78E-6CB1-43AE-99D6-02B5BC99A87AQ36706582-0A8D17DA-34A4-44D3-A437-8ACF496B8956Q37221548-04233B7C-A47F-4066-84DE-EFC4EB5315A0Q38274711-75848B44-822A-4A44-B3EF-697A2A9B2F93Q38705396-74EB19C3-92DC-4ECD-A1BD-F8DEF5AD77BEQ39068539-D138CFF6-F990-4F60-865B-A48D479BBC35Q39585096-6FF93A75-ECA2-4B56-A26D-1937D31891C1Q41986575-F1CA3B4A-4E7F-4B1F-A564-DE1DF7A68753Q43167343-3524997D-5CDA-44D0-964B-CCCEDBF789BFQ46646011-DD426A53-ACBB-4B28-9B8A-F1F8C29480C0Q46936424-10024C6D-6810-4943-8FFB-E42E917C60DBQ50013552-1515B4F1-A57A-458D-8D39-A4AB344D70C0Q55400868-3175FA23-73C1-4AA5-87D2-220AC117DBA5
P2860
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@ast
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@en
type
label
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@ast
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@en
prefLabel
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@ast
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@en
P2093
P1433
P1476
Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery.
@en
P2093
Damiano RE
Epstein RJ
Forstot SL
Majmudar PA
Nirankari VS
P356
10.1016/S0161-6420(99)00019-6
P577
2000-01-01T00:00:00Z